Thursday, Sep 17, 2009
MISB operates a chain of aesthetic clinics in Singapore and Hong Kong through its wholly-owned subsidiary, Astique Medical Pte Ltd. MISB is proposing to restructure the rated facilities by way of conversion into loan stocks of up to RM254.85 million, comprising redeemable convertible secured loan stocks (RCSLS) of up to RM235.85 million and redeemable convertible unsecured loan stocks (RCULS) of up to RM19.0 million. The proposal to issue RCSLS and RCULS, which need not be rated, is pending approval from Securities Commission.
MISB’s next scheduled redemption of Tranche 4 of the IMTN facility amounting to RM20.0 million is due in March 2010; however, its RM2.05 million profit payment is due on September 22, 2009. MARC has been informed that RM2.0 million of the upcoming profit payment will be likely rolled into the proposed loan stock issuance. MISB has obtained noteholders’ indulgence for the deferment of its RM2.0 million profit payment until the date of issuance of the proposed loan stocks or by October 31, 2009, whichever is earlier. The balance profit payment of RM50,000 to be paid on the original due date will be met from its internally generated funds.
MARC will monitor the progress of the proposed restructuring exercise and MISB’s ability to meet its payment obligations under the notes.
Contacts: Rajan Paramesran, 03-2090 2233/ rajan@marc.com.my; Elea Nor Zainal, 03-2090 2263/ elea@marc.com.my; Katherine Hee, 03-2090 2273/ hcmay@marc.com.my